Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

A Multidimensional Intervention to Improve Ethical Decision-Making Competence Among Nursing Student Interns

5. november 2026 oppdatert av: Qiuyu Zhang, Yangzhou University

The goal of this randomized controlled trial is to evaluate the effectiveness of a 5-week multidimensional intervention in improving ethical decision-making competence among nursing student interns. The intervention is designed to address multiple factors influencing ethical decision-making during clinical training. The study will also examine whether the effects of the intervention are maintained at 1-month and 3-month follow-ups after the intervention ends.

The main questions it aims to answer are:

  1. Does the 5-week multidimensional intervention improve ethical decision-making competence among nursing student interns compared with usual clinical internship training?
  2. Are the effects of the intervention maintained at 1-month and 3-month follow-ups after the intervention ends?

Researchers will compare nursing student interns who receive the 5-week multidimensional intervention with those who receive usual clinical internship training to evaluate the intervention's effectiveness.

Participants will:

  1. Complete questionnaires assessing all study outcome measures at baseline, at the end of the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention ends.
  2. Participate in the educational activities provided to their assigned study group.
  3. Complete follow-up assessments as scheduled.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

108

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Undergraduate nursing student interns undertaking clinical internships at tertiary Grade A hospitals.
  2. First-time hospital interns with no more than 3 months of internship experience.
  3. Good communication and language expression skills.
  4. Willingness to participate in the study and provide informed consent.

Exclusion Criteria:

  1. Individuals with a history of mental illness or communication difficulties.
  2. Nursing student interns who discontinue their hospital internship or take a leave of absence from their studies during the study period.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Multidimensional Intervention Group

Participants assigned to this group will receive a 5-week multidimensional intervention designed to improve ethical decision-making competence among nursing student interns during clinical learning. The intervention will address factors relevant to ethical decision-making through structured educational activities. Participants will complete outcome assessments at baseline, at the end of the intervention, and at 1-month and 3-month follow-ups after the intervention ends.

A 5-week multidimensional educational intervention to improve ethical decision-making competence among nursing student interns. Sessions will be delivered once weekly, lasting 1.5-2 hours each. The intervention includes five modules: (1) ethical issue recognition; (2) ethical emotion regulation; (3) ethical reasoning and decision-making; (4) ethical expression and action; and (5) clinical teaching rounds. The intervention aims to strengthen participants' ethical awareness, emotional regulation, decision-making, and ability to address ethical challenges during clinical learning.

Participants in the usual clinical internship training group will receive routine clinical learning and teaching according to the hospital's established training program. Regular activities include clinical skills training, observation and participation in nursing care under the supervision of clinical instructors, case discussions. When encountering ethical issues during clinical learning, participants will generally seek advice from their clinical instructors or supervising nurses. No additional study-specific intervention will be provided.

Aktiv komparator: Usual Clinical Internship Training Group

Participants assigned to this group will receive usual clinical internship training according to the hospital's standard training arrangements. They will not receive the study-specific 5-week multidimensional intervention during the intervention period. Participants will complete outcome assessments at baseline, at the end of the 5-week intervention period, and at 1-month and 3-month follow-ups after the intervention period ends.

Participants in the usual clinical internship training group will receive routine clinical learning and teaching according to the hospital's established training program. Regular activities include clinical skills training, observation and participation in nursing care under the supervision of clinical instructors, case discussions. When encountering ethical issues during clinical learning, participants will generally seek advice from their clinical instructors or supervising nurses. No additional study-specific intervention will be provided.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Ethical Decision-Making Competence Scale
Tidsramme: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

The scale consists of 18 items across four dimensions and assesses nursing students' creativity, confidence, awareness, and neutrality when facing ethical decision-making dilemmas involving patients or their families. It is based on Rest's Four-Component Model of Ethical Decision-Making, comprising ethical judgment, ethical sensitivity, ethical motivation, and ethical action. Each item is rated on a 5-point Likert scale ranging from 0 (strongly disagree) to 4 (strongly agree). The total score ranges from 0 to 72, with higher scores indicating a higher level of ethical decision-making competence.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Clance Impostor Phenomenon Scale
Tidsramme: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

This scale measures nurses' levels of imposter phenomenon and their attributions. It consists of 18 items across three dimensions: passive concealment (4 items), external attribution (6 items), and self-doubt (8 items). Each item is rated on a 5-point Likert scale ranging from 1 ("completely inconsistent") to 5 ("completely consistent"). The total score ranges from 18 to 90, with higher scores indicating a more severe imposter phenomenon.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.
Rushton Moral Resilience Scale
Tidsramme: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

The scale consists of 17 items across three dimensions: coping with nursing ethical dilemmas and relational integrity (10 items), personal integrity (2 items), and ethical efficacy in nursing (5 items). Each item is rated on a 4-point Likert scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). The total score ranges from 17 to 68, with higher scores indicating greater ethical resilience.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.
Moral Sensitivity Questionnaire for Nursing Students
Tidsramme: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

This scale measures nursing students' moral sensitivity and consists of 11 items across three dimensions: moral strength (4 items), moral burden (5 items), and moral responsibility (2 items). Each item is rated on a 6-point Likert scale ranging from 1 ("strongly disagree") to 6 ("strongly agree"). The total score ranges from 11 to 66, with higher scores indicating greater moral sensitivity.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.
Professional Quality Of Life Scale
Tidsramme: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

The scale consists of three dimensions: compassion satisfaction (CS), burnout (BO), and secondary traumatic stress (STS). CS represents a positive aspect, whereas BO and STS represent negative aspects. Items are rated on a 5-point Likert scale ranging from 1 ("never") to 5 ("always"). The cutoff scores for CS, BO, and STS are 27, and >17, respectively. Compassion fatigue severity is classified as mild when one dimension exceeds its cutoff, moderate when two dimensions exceed their cutoffs, and severe when all three dimensions exceed their cutoffs.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

1. mars 2027

Studiet fullført (Antatt)

1. april 2027

Datoer for studieregistrering

Først innsendt

19. oktober 2026

Først innsendt som oppfylte QC-kriteriene

19. oktober 2026

Først lagt ut (Faktiske)

26. oktober 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

5. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • YXYLL-2025-140

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere